Autosomal Dominant Spinocerebellar Ataxias and Social Cognition
Recruiting
N/A
Interventional Study
Autosomal Dominant Spinocerebellar Ataxia (SCA1, 2,3,6,7,27B)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 100
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 160 (estimated)
- Sponsor
- University Hospital, Angers · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Spinocerebellar ataxias are a group of rare neurodegenerative diseases, clinically and genetically highly heterogeneous, with an estimated mean prevalence of 2.7 per 100,000 population. The term "spinocerebellar ataxia" or "SCA" is often used for ataxias of genetic origin of autosomal dominant transmission, which are the subject of this study. Recent studies of social cognition in patients with ge…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
For all participants:
* Men or women aged 18 and over
* At least 7 years' schooling (CEP level)
* Ability to read, write and speak French
* Signed informed consent to participate in the study
For patients :
\- With molecularly confirmed autosomal dominant spinocerebellar atax…
Contacts